Search research articles
Contact Us
Filters
Showing results (51-60 of 109) with videos related to
Page
of 11
Sort By:
Journal of Cancer Research and Clinical Oncology
|
July 10, 2003
Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion
Ivana Zavrski, Cord Naujokat, Kathrin Niemöller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 17, 2008
mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors
Björn Hegner, Maria Lange, Angelika Kusch, et al.
Journal of Cancer Research and Clinical Oncology
|
July 27, 2005
Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study
Peter Schmid, Volker Heilmann, Carsten-Oliver Schulz, et al.
Anti-Cancer Drugs
|
October 30, 2004
Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma
Jan Eucker, Katharina Bängeroth, Ivana Zavrski, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 16, 2011
Information disclosure to cancer patients: EORTC QLQ-INFO25 questionnaire
Juan Ignacio Arraras, Eva Greimel, Wei-Chu Chie, et al.
Anti-Cancer Drugs
|
October 24, 2002
The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkin's lymphomas
Jan Eucker, Claudia Schille, Peter Schmid, et al.
Psycho-Oncology
|
November 5, 2011
Cross-cultural differences in information disclosure evaluated through the EORTC questionnaires
Juan Ignacio Arraras, Eva Greimel, Wei-Chu Chie, et al.
Clinical Lymphoma & Myeloma
|
January 19, 2007
Bortezomib-induced tumor lysis syndrome in multiple myeloma
Orhan Sezer, David H Vesole, Seema Singhal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 3, 2010
An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients
Juan Ignacio Arraras, Eva Greimel, Orhan Sezer, et al.
Journal of Cancer Research and Clinical Oncology
|
June 19, 2004
Expression of receptor activator of NF-kappaB ligand (RANKL) mRNA in human multiple myeloma cells
Ulrike Heider, Ivana Zavrski, Christian Jakob, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 109) with videos related to
Sort By:
Page
of 11
Journal of Cancer Research and Clinical Oncology
|
July 10, 2003
Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion
Ivana Zavrski, Cord Naujokat, Kathrin Niemöller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 17, 2008
mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors
Björn Hegner, Maria Lange, Angelika Kusch, et al.
Journal of Cancer Research and Clinical Oncology
|
July 27, 2005
Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study
Peter Schmid, Volker Heilmann, Carsten-Oliver Schulz, et al.
Anti-Cancer Drugs
|
October 30, 2004
Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma
Jan Eucker, Katharina Bängeroth, Ivana Zavrski, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 16, 2011
Information disclosure to cancer patients: EORTC QLQ-INFO25 questionnaire
Juan Ignacio Arraras, Eva Greimel, Wei-Chu Chie, et al.
Anti-Cancer Drugs
|
October 24, 2002
The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkin's lymphomas
Jan Eucker, Claudia Schille, Peter Schmid, et al.
Psycho-Oncology
|
November 5, 2011
Cross-cultural differences in information disclosure evaluated through the EORTC questionnaires
Juan Ignacio Arraras, Eva Greimel, Wei-Chu Chie, et al.
Clinical Lymphoma & Myeloma
|
January 19, 2007
Bortezomib-induced tumor lysis syndrome in multiple myeloma
Orhan Sezer, David H Vesole, Seema Singhal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 3, 2010
An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients
Juan Ignacio Arraras, Eva Greimel, Orhan Sezer, et al.
Journal of Cancer Research and Clinical Oncology
|
June 19, 2004
Expression of receptor activator of NF-kappaB ligand (RANKL) mRNA in human multiple myeloma cells
Ulrike Heider, Ivana Zavrski, Christian Jakob, et al.
Page
of 11